19 May 2013
Keywords: teva, pays, 5m, active, bio, ms, drug
Article | 21 June 2004
Israel's Teva Pharmaceutical Industries and Active Biotech AB of Sweden have signed an agreement to develop and commercialize laquinimod, the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 June 2004
17 May 2013
© 2013 thepharmaletter.com